|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TRANSLATIONAL AND CLINICAL RESEARCH: MESENCHYMAL STEM CELLS SERIES |
aDepartment of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, New York, USA;
bDepartment of Physiology and Biophysics, State University of New York at Stony Brook, Stony Brook, New York, USA;
cDepartment of Pharmacology, Columbia University, New York, New York, USA;
dDepartment of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts, USA;
eInstitute for Molecular Cardiology, State University of New York at Stony Brook, Stony Brook, New York, USA;
fCenter for Molecular Therapeutics, Columbia University, New York, New York, USA
Key Words. Human mesenchymal stem cells • Cell labeling • Cell tracking • Nanotechnology • Imaging
Correspondence: Amy B. Rosen, Ph.D., Institute for Molecular Cardiology, State University of New York at Stony Brook, Stony Brook, New York 11794, USA. Telephone: 631-444-7391; Fax: 631-444-3432; e-mail: amybrosen{at}gmail.com
Received November 8, 2006;
accepted for publication May 4, 2007.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLS EXPRESS May 10, 2007.
Stem cells show promise for repair of damaged cardiac tissue. Little is known with certainty, however, about the distribution of these cells once introduced in vivo. Previous attempts at tracking delivered stem cells have been hampered by the autofluorescence of host tissue and limitations of existing labeling techniques. We have developed a novel loading approach to stably label human mesenchymal stem cells with quantum dot (QD) nanoparticles. We report the optimization and validation of this long-term tracking technique and highlight several important biological applications by delivering labeled cells to the mammalian heart. The bright QD crystals illuminate exogenous stem cells in histologic sections for at least 8 weeks following delivery and permit, for the first time, the complete three-dimensional reconstruction of the locations of all stem cells following injection into the heart.
This article has been cited by other articles:
![]() |
P. A. Walker, S. K. Shah, M. T. Harting, and C. S. Cox Jr Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation Dis. Model. Mech., January 1, 2009; 2(1-2): 23 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Potapova, S. V. Doronin, D. J. Kelly, A. B. Rosen, A. J. T. Schuldt, Z. Lu, P. V. Kochupura, R. B. Robinson, M. R. Rosen, P. R. Brink, et al. Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2257 - H2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Noh, Y. T. Lim, and B. H. Chung Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals FASEB J, November 1, 2008; 22(11): 3908 - 3918. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mias, E. Trouche, M.-H. Seguelas, F. Calcagno, F. Dignat-George, F. Sabatier, M.-D. Piercecchi-Marti, L. Daniel, P. Bianchi, D. Calise, et al. Ex Vivo Pretreatment with Melatonin Improves Survival, Proangiogenic/Mitogenic Activity, and Efficiency of Mesenchymal Stem Cells Injected into Ischemic Kidney Stem Cells, July 1, 2008; 26(7): 1749 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pawelczyk, A. S. Arbab, A. Chaudhry, A. Balakumaran, P. G. Robey, and J. A. Frank In Vitro Model of Bromodeoxyuridine or Iron Oxide Nanoparticle Uptake by Activated Macrophages from Labeled Stem Cells: Implications for Cellular Therapy Stem Cells, May 1, 2008; 26(5): 1366 - 1375. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
